The company collaborated with the Seattle Children's Hospital on a test job that it says would have cost an estimated $3m (£1.9m) if it had used traditional on-premises hardware, but cost little more than $18,000 using a hybrid approach.
As part of the test job, the collaborators ran a large chain protein sequence through Blast, a software tool designed to churn through databases. Drug companies frequently use it in the process of designing new drugs to tell how the human body will react before moving into additional phases of testing.
|